CYTOKINES : TOOLS AND TARGETS FOR TOMORROW'S THERAPIES
October 15-17, 1997
Institut Pasteur, Paris, France.
Chairpersons : Jean-Marc Cavaillon (Institut Pasteur, France), Charles
A. Dinarello (University of Colorado Health Center, United-States)
Bernard Rouveix (Htpital Cochin, France), Philippe Sansonetti
(Institut Pasteur, France)
October 15, 1997, 2.00 p.m. Pre-conference associated meeting [FREE
ADMISSION]
IMMUNOINTERVENTION : PRESENT AND FUTURE
Cellular and Molecular Basis
Chairpersons : C. Griscelli (France), F. Kourilsky (France), F. Rosen
(USA), S. Schlossman (USA).
Invited speakers : P. Debri (France), N. Gualdi (France), F. Lemonnier
(France), L. Moretta (Switzerland), W. Paul (USA), M. Pierres
(France), J. Thhze (France)
and followed by the 5th Benacerraf Conference : "Anti-viral immunity"
by R. Zinkernagel (Nobel Laureate of Medicine, 1996).
October 16, 1997
PHARMACOLOGY OF CYTOKINES
- P. Ghezzi (Italy) : Pharmacologically-oriented introduction to the
cytokine network. - B. Rouveix (France) : Clinical pharmacology of
cytokines.
CYTOKINES IN INFLAMMATION
- C. A. Dinarello (USA) : Blocking Interleukin-1 and Tumor Necrosis
Factor in disease. - M. Feldmann (U.K.) : Anti-TNFa therapy of
rheumatoid arthritis : what does it teach us about the cytokine
network ? - M. Goldman (Belgium) Interleukin-10 as an anti-stress
cytokine. - J.J. Garaud & A. LeBeaut (USA) : Clinical development
of interleukin 10. - G. Trinchieri (USA) Biological properties and
therapeutic applications of IL-12.
HEMATOPOIETIC FACTORS
- C. Lacombe (France) : Erythropoietin : from molecular biology to
clinical use.
- W. Vainchenker (France) : Thrombopoietin and biological effects. -
J. Caraux (France) : New growth factor approaches to control toxicity
of cancer chemotherapy.
October 17, 1997
IMMUNOINTERVENTIONS IN INFECTION
- H. Cliff Lane (USA) The Potential Role of Interleukin-2 (IL-2) in
the Management of Patients with HIV Infection - P. Galanaud (France)
Immunointervention based on Th2-type cytokines in HIV infection. -
M.-P. Glauser (Switzerland) Cytokines in severe infections : from
pathophysiology to clinical applications. - O. Lyon-Caen (France) : b
Interferon and multiple sclerosis. - T. Poynard (France) :
Interferon ` in the treatment of hepatitis C.
IMMUNOINTERVENTIONS IN CANCER
- W. H. Fridman (France) : Cytokines as prognostic and therapeutic
agents in human cancer - B. Klein (France) : IL-6 related cytokines
and multiple myeloma. - G. Forni (Italy) : The dream of effective
cytokine-based tumor vaccines.
- ROUND TABLE - Cytokines in tomorrow's therapy : pharmaco-economic
consequences.
T. Lebrun (France), H.Cliff Lane (USA), T.Marcel (France), F. Sauer
(UK)
Other conferences:
New targets for new antibiotics June 4-6, 1997.
Future therapies for an anxious world : New approaches to the
treatment of O.C.D. disorders and other anxiety troubles. November
24-26, 1997.
New trends in vaccine R&D: adjuvants, delivery systems and antigen
formulations. February 26-28, 1998.
New therapeutic approaches for allergic diseases of the respiratory
tract. April 2-4, 1998.
English will be used by the speakers
For details, please return to : INSTITUT PASTEUR EURj CONFERENCES, 28,
rue du docteur Roux - 75724 Paris Cedex 15- France. Fax : 33 (0) 1 40
61 34 05 - E.Mail : ldrye at pasteur.frhttp://www.pasteur.fr/Conf/euroconf.html